To include your compound in the COVID-19 Resource Center, submit it here.

Visudyne verteporfin: Long-term data; marketed

In a 3-year, open-label extension to 2, 2-year double-blinded, placebo-controlled, international Phase

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE